Industry News

By Steven Ross Johnson  | November 28, 2016 Falling demand for blood is creating financial challenges and fueling uncertainty for organizations depended on to maintain the nation’s blood supply, according to a new study sponsored by the federal government. Changes in clinical pr

LA JOLLA, Calif., Nov. 29, 2016 /PRNewswire/ — StemGenex recently submitted comments to the Food and Drug Administration (FDA) docket on the future regulation of adult adipose-derived stem cell treatments, “Draft Guidances Relating to the Regulation of Human Cells, Tissues

Kentucky beat Tennessee in this year’s Big Blue Crush blood drive. The Big Blue Crush blood drive is an annual competition hosted by the Kentucky Blood Center between Kentucky and Tennessee to see who can collect the most blood. This year was the 29th year of the blood drive competiti

Transfusion Thresholds For many years, the findings of the Transfusion Requirements in Critical Care (TRICC) trial guided packed red blood cell (pRBC) administration in the intensive care unit (ICU).[1] This multicenter, randomized controlled trial (RCT) compared a conservative transf

The San Diego Chargers have a strong relationship with the San Diego Blood Bank that dates back 38 years. In fact, the Bolts’ annual blood drive is the largest of it’s kind in the country. Their relationship will be taken to the next level with an all new Blood Bank Donor Wellness Cen

AABB’s new guidelines included two primary recommendations. First, a restrictive red blood cell (RBC) transfusion threshold of 7 g/dL — rather than 10 g/dL — should be used for hospitalized, hemodynamically stable adults. Second, an 8 g/dL threshold is recommended for patients undergo

SDBB, Sinopia partner to extend shelf life of red blood cells San Diego Thursday, November 03, 2016, 13:00 Hrs  [IST] The San Diego Blood Bank (SDBB), primary supplier of blood to the majority of hospitals in San Diego County, announced it is partnering with Sinopia Biosciences, Inc.

According to the market research report “Tissue Banking Market Analysis: By Tissue (Bone, Skin, Heart Valves, Soft tissues, Corneas, Umbilical Cord); By Equipment (Cryopreservation systems, Thawing equipment and others); By Application (Clinical, Cosmetic, Research) & By Geography

SEATTLE, WA–(Marketwired – Oct 19, 2016) – Nohla Therapeutics Inc. (Nohla), a leading developer of universal donor cellular therapies for the treatment of patients with life threatening hematological disorders, announced today the signing of an exclusive supply agree